Format

Send to

Choose Destination
  • PMID: 30865028 was deleted because it is a duplicate of PMID: 31090574
Curr Opin Pediatr. 2019 Jun;31(3):330-339. doi: 10.1097/MOP.0000000000000751.

Genetic causes of surfactant protein abnormalities.

Author information

1
Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Abstract

PURPOSE OF REVIEW:

Mutations in genes encoding proteins critical for the production and function of pulmonary surfactant cause diffuse lung disease. Timely recognition and diagnosis of affected individuals is important for proper counseling concerning prognosis and recurrence risk.

RECENT FINDINGS:

Involved genes include those encoding for surfactant proteins A, B, and C, member A3 of the ATP-binding cassette family, and for thyroid transcription factor 1. Clinical presentations overlap and range from severe and rapidly fatal neonatal lung disease to development of pulmonary fibrosis well into adult life. The inheritance patterns, course, and prognosis differ depending upon the gene involved, and in some cases the specific mutation. Treatment options are currently limited, with lung transplantation an option for patients with end-stage pulmonary fibrosis. Additional genetic disorders with overlapping pulmonary phenotypes are being identified through newer methods, although these disorders often involve other organ systems.

SUMMARY:

Genetic disorders of surfactant production are rare but associated with significant morbidity and mortality. Diagnosis can be made invasively through clinically available genetic testing. Improved treatment options are needed and better understanding of the molecular pathophysiology may provide insights into treatments for other lung disorders causing fibrosis.

PMID:
31090574
PMCID:
PMC6530488
[Available on 2020-06-01]
DOI:
10.1097/MOP.0000000000000751

Supplemental Content

Loading ...
Support Center